Abstract
The aim of the study is to evaluate the long-term clinical results of amniotic membrane transplantation (AMT) combined with mitomycin C (MMC) for reconstruction of conjunctival defects created during the excision of ocular surface squamous neoplasia (OSSN). Eight consecutive eyes of seven patients (five males and two females; mean age, 64 ± 19 years) treated by one surgeon (KH) were included in this study. AMT was performed after excision of a mass region, along with 0.04 % MMC treatment for the exposed sclera. The tumor size, histopathological retrieval, AM graft size after tumor excision, recurrence, and postoperative complications were recorded. During a mean postoperative follow-up period of 60.9 ± 14.6 months (range 36–78 months), the ocular surfaces completely re-epithelialized in all cases. The median size of the tumor was 44.4 ± 21.2 mm2 (range 13–67 mm2). The histopathological diagnoses were five cases of squamous cell carcinoma in situ (SCC in situ) and three cases of dysplasia. The median size of the AM graft after tumor excision was 100.8 ± 32.7 mm2 (range 49–151 mm2). A case of recurrent SCC in situ with a preoperative history of using MMC eye drops developed further corneal limbal deficiency and was treated with therapeutic soft contact lenses. A case of dysplasia with a history of large pterygial excision developed symblepharon postoperatively was treated with AMT 6 months after tumor excision. The tumors recurred in two eyes with SCC in situ and were successfully treated with continuous AMT and MMC. No severe complications, such as infections, corneal or scleral thinning, or ulceration developed in all cases. The combination of AMT and MMC is effective for safe reconstruction over the long-term after the excision of OSSN with postoperative careful observation and treatment. In recurrent tumor excision cases, AMT is a suitable technique for repeated ocular surface reconstruction.
Similar content being viewed by others
References
Shields JA, Shields CL, DePotter P (1997) Surgical management of conjunctival tumors: the 1994 Lynn B McMahan Lecture. Arch Ophthalmol 115:808–815
Kim JC, Tseng SCG (1995) Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 14:472–484
Tsubota K, Satake Y, Ohyama M, Toda I, Takano Y, Ono M, Shinozaki N, Shimazaki J (1996) Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol 122:38–52
Shimazaki J, Yang H-Y, Tsubota K (1997) Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology 104:2068–2076
Lee SH, Tseng SCG (1997) Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 123:303–312
Shimazaki J, Shinozaki N, Tsubota K (1998) Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol 82:235–240
Kruse FE, Rohrschneider K, Völcker HE (1999) Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology 106:1504–1511
Hanada K, Shimazaki J, Shimmura S, Tsubota K (2001) Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera. Am J Ophthalmol 131:324–331
Shields CL, Shields JA, Armstrong T (2001) Management of conjunctival and corneal melanoma with surgical excision, amniotic membrane allograft, and topical chemotherapy. Am J Ophthalmol 132:576–578
Espana EM, Prabhasawat P, Gruetrich M, Solomon A, Tseng SCG (2002) Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. Br J Ophthalmol 86:640–645
Gündüz K, Uçakhan ÖÖ, Kanpolat A, Günalp I (2006) Nonpreserved human amniotic membrane transplantation for conjunctival reconstruction after excision of extensive ocular surface neoplasia. Eye 20:351–357
Asoklis RS, Damijonaityte A, Butkiene L, Makselis A, Petroska D, Pajaujis M, Juodkaite G (2011) Ocular surface reconstruction using amniotic membrane following excision of conjunctival and limbal tumors. Eur J Ophthalmol 21:552–558
Tseng SCG, Prabhasawat P, Barton K, Gray T, Meller D (1998) Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 116:431–441
Tsubota K, Satake Y, Kaido M, Shinozaki N, Shimmura S, Bissen-Miyajima H, Shimazaki J (1999) Treatment of severe ocular surface disorders with corneal epithelial stem-cell transplantation. N Engl J Med 340:1697–1703
Frucht-Pery J, Rozenman Y (1994) Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol 117:164–168
Wilson MW, Hungerford JL, George SM, Madreperla SA (1997) Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol 124:303–311
Heigle TJ, Stulting RD, Palay DA (1997) Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C. Am J Ophthalmol 124:397–399
Frucht-Pery J, Sugar J, Baum J, Sutphin JE, Pe’er J, Savir H, Holland EJ, Meisler DM, Foster JA, Folberg R, Rozenman Y (1997) Mitomycin C treatment for conjunctival- corneal intraepithelial neoplasia—a multicenter experience. Ophthalmology 104:2085–2093
Rozenman Y, Frucht-Pery J (2000) Treatment of conjunctival corneal intraepithelial neoplasia with topical drops of mitomycin C. Cornea 19:1–6
Shields CL, Naseripour M, Shields JA (2002) Topical mitomycin C for extensive recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol 133:601–606
Tseng SCG, Li DQ, Max X (1999) Suppression of transforming growth factor isoforms, TGF-β receptor II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol 179:325–335
Lee SB, Li DQ, Tan DT, Meller DC, Tseng SC (2000) Suppression of TGF-β signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane. Curr Eye Rec 20:325–334
Hayasaka S, Noda S, Yamamoto Y, Setogawa T (1988) Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium. Am J Ophthalmol 106:715–718
Hayasaka S, Noda S, Yamamoto Y, Setogawa T (1989) Postoperative instillation of mitomycin C in the treatment of recurrent pterygium. Ophthal Surg 20:580–583
Chen CW, Huang HT, Bair JS (1990) Trabeculectomy with simultaneous topical application of mitomycin C in refractory glaucoma. J Ocul Pharmacol 6:175–182
Palmer SS (1991) Mitomycin C as adjunct chemotherapy with trabeculectomy. Ophthalmology 98:317–321
Tseng SC, Di Pascuale MA, Liu DT, Gao YY, Baradaran-Rafii A (2005) Intraoperative mitomycin C and amniotic membrane transplantation for fornix reconstruction in severe cicatricial ocular surface diseases. Ophthalmology 112:896–903
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hanada, K., Nishikawa, N., Miyokawa, N. et al. Long-term outcome of amniotic membrane transplantation combined with mitomycin C for conjunctival reconstruction after ocular surface squamous neoplasia excision. Int Ophthalmol 37, 71–78 (2017). https://doi.org/10.1007/s10792-016-0231-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-016-0231-6